Cargando…

Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?

Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokolski, Mateusz, Kalużna-Oleksy, Marta, Tycińska, Agnieszka, Jankowska, Ewa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452788/
https://www.ncbi.nlm.nih.gov/pubmed/37626719
http://dx.doi.org/10.3390/biomedicines11082222
_version_ 1785095758953840640
author Sokolski, Mateusz
Kalużna-Oleksy, Marta
Tycińska, Agnieszka
Jankowska, Ewa A.
author_facet Sokolski, Mateusz
Kalużna-Oleksy, Marta
Tycińska, Agnieszka
Jankowska, Ewa A.
author_sort Sokolski, Mateusz
collection PubMed
description Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF and forcing the systems to be reorganised with the implementation and development of telemedical technologies. The main challenges for HF patients during the pandemic could be solved with new technologies aimed to limit the risk of SARS-CoV-2 transmission, optimise and titrate the therapy, prevent the progression and worsening of HF, and monitor patients with acute HF events in the course of and after COVID-19. Dedicated platforms, phone calls or video conferencing and consultation, and remote non-invasive and invasive cardiac monitoring became potential tools used to meet the aforementioned challenges. These solutions showed to be effective in the model of care for patients with HF and undoubtedly will be developed after the experience of the pandemic. However, the multitude of possibilities requires central coordination and collaboration between institutes with data protection and cost reimbursement to create effective mechanisms in HF management. It is crucial that lessons be learned from the pandemic experience to improve the quality of care for HF patients.
format Online
Article
Text
id pubmed-10452788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104527882023-08-26 Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned? Sokolski, Mateusz Kalużna-Oleksy, Marta Tycińska, Agnieszka Jankowska, Ewa A. Biomedicines Review Numerous studies showed that patients with heart failure (HF) and COVID-19 are at high risk of in-hospital complications and long-term mortality. Changes in the organisation of the medical system during the pandemic also worsened access to standard procedures, increasing the general mortality in HF and forcing the systems to be reorganised with the implementation and development of telemedical technologies. The main challenges for HF patients during the pandemic could be solved with new technologies aimed to limit the risk of SARS-CoV-2 transmission, optimise and titrate the therapy, prevent the progression and worsening of HF, and monitor patients with acute HF events in the course of and after COVID-19. Dedicated platforms, phone calls or video conferencing and consultation, and remote non-invasive and invasive cardiac monitoring became potential tools used to meet the aforementioned challenges. These solutions showed to be effective in the model of care for patients with HF and undoubtedly will be developed after the experience of the pandemic. However, the multitude of possibilities requires central coordination and collaboration between institutes with data protection and cost reimbursement to create effective mechanisms in HF management. It is crucial that lessons be learned from the pandemic experience to improve the quality of care for HF patients. MDPI 2023-08-08 /pmc/articles/PMC10452788/ /pubmed/37626719 http://dx.doi.org/10.3390/biomedicines11082222 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sokolski, Mateusz
Kalużna-Oleksy, Marta
Tycińska, Agnieszka
Jankowska, Ewa A.
Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title_full Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title_fullStr Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title_full_unstemmed Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title_short Telemedicine in Heart Failure in the COVID-19 and Post-Pandemic Era: What Have We Learned?
title_sort telemedicine in heart failure in the covid-19 and post-pandemic era: what have we learned?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452788/
https://www.ncbi.nlm.nih.gov/pubmed/37626719
http://dx.doi.org/10.3390/biomedicines11082222
work_keys_str_mv AT sokolskimateusz telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned
AT kaluznaoleksymarta telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned
AT tycinskaagnieszka telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned
AT jankowskaewaa telemedicineinheartfailureinthecovid19andpostpandemicerawhathavewelearned